V. Desplat

C. Doutremépuich, V. Desplat, P. Belon, 2009, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Reverse Effect of Aspirin: Is the Prothrombotic Effect after Aspirin Discontinuation Mediated by Cyclooxygenase 2 Inhibition?

C. Doutremépuich, V. Desplat, O. Aguejouf, 2008, Pathophysiology of Haemostasis and Thrombosis.

EP2 and EP4 receptor subtypes in human bone marrow stromal cells

B. Petit, V. Praloran, Y. Denizot, 1999, British journal of haematology.

MYELOID NEOPLASIA A new human mast cell line expressing a functional IgE receptor converts to tumorigenic growth by KIT D 816 V transfection

T. Rülicke, P. Valent, P. Dubreuil, 2014 .

Paradoxical thrombotic effects of aspirin: experimental study on 1000 animals.

C. Doutremépuich, V. Desplat, O. Aguejouf, 2010, Cardiovascular & hematological disorders drug targets.

Paradoxical Effect of Aspirin

C. Doutremépuich, V. Desplat, O. Aguejouf, 2012, Thrombosis.

Thrombotic Events Associated to Aspirin Therapy

C. Doutremépuich, V. Desplat, O. Aguejouf, 2011, Thrombosis.

Is there a role of platelet-activating factor in human lung cancer?

Y. Denizot, V. Desplat, B. Melloni, 2001, Lung cancer.

New ferrocenic pyrrolo[1,2-a]quinoxaline derivatives: synthesis, and in vitro antimalarial activity--Part II.

G. Déléris, J. Leger, C. Jarry, 2011, European journal of medicinal chemistry.

New ferrocenic pyrrolo[1,2-a]quinoxaline derivatives: synthesis, and in vitro antimalarial activity.

V. Sinou, D. Parzy, C. Jarry, 2008, Bioorganic & medicinal chemistry.

Synthesis and evaluation of the antiproliferative activity of novel isoindolo[2,1-a]quinoxaline and indolo[1,2-a]quinoxaline derivatives

G. Déléris, C. Jarry, D. Thiolat, 2011, Journal of enzyme inhibition and medicinal chemistry.

Synthesis of New Pyrrolo[1,2-a]quinoxaline Derivatives as Potential Inhibitors of Akt Kinase

C. Jarry, D. Thiolat, S. Massip, 2008, Journal of enzyme inhibition and medicinal chemistry.

Synthesis, analytical behaviour and biological evaluation of new 4-substituted pyrrolo[1,2-a]quinoxalines as antileishmanial agents.

J. Leger, C. Jarry, M. Mamani-Matsuda, 2007, Bioorganic & medicinal chemistry.

Synthesis and evaluation of the cytotoxic activity of novel ethyl 4-[4-(4-substitutedpiperidin-1-yl)]benzyl-phenylpyrrolo[1,2-a]quinoxaline-carboxylate derivatives in myeloid and lymphoid leukemia cell lines.

F. Rossi, S. Routier, M. Marchivie, 2016, European journal of medicinal chemistry.

Synthesis and biological evaluation of novel substituted pyrrolo[1,2-a]quinoxaline derivatives as inhibitors of the human protein kinase CK2.

J. Jose, M. Marchivie, N. Pinaud, 2013, European journal of medicinal chemistry.

Synthesis, Crystal Structure and Anti-leukemic Activity of 4-{4-[(4-(2-Oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidin-1-yl)benzyl]}-3-phenyl-3H-pyrrolo[2,3-c]quinoline

F. Rossi, M. Marchivie, N. Pinaud, 2018, Journal of Chemical Crystallography.

Synthesis and Antiproliferative Effect of Ethyl 4‐[4‐(4‐Substituted Piperidin‐1‐yl)]benzylpyrrolo[1,2‐a]quinoxalinecarboxylate Derivatives on Human Leukemia Cells

Pascal Sonnet, Sandra Rubio, Mathieu Marchivie, 2017, ChemMedChem.

Crystal structure of [2]benzopyrano[3,4-b]quinoxalin-5-one through spontaneous air oxidation rearrangement of 6-Chloro-isoindolo[2,1-a]quinoxaline

G. Déléris, S. Massip, V. Desplat, 2012 .

Synthesis of new 4-(E)-alkenylpyrrolo[1,2-a]quinoxalines as antileishmanial agents by Suzuki-Miyaura cross-coupling reactions

C. Jarry, D. Thiolat, S. Massip, 2007, Journal of enzyme inhibition and medicinal chemistry.

Modulation of cell proliferation in rat liver cell cultures by new calix[4]arenes

G. Lescoat, C. Jarry, F. Gaboriau, 2006, Journal of enzyme inhibition and medicinal chemistry.

Metabolism and effect of platelet-activating factor on the growth of human myeloma cell lines.

V. Praloran, Y. Denizot, V. Desplat, 2000, Cancer letters.

Effects of Ultra-Low-Dose Aspirin in Thrombosis and Haemorrhage

C. Doutremépuich, V. Desplat, P. Belon, 2019, Homeopathy.

Hematopoietic niche drives FLT3-ITD acute myeloid leukemia resistance to quizartinib via STAT5-and hypoxia-dependent upregulation of AXL

P. Dubus, V. Praloran, I. Dusanter-Fourt, 2019, Haematologica.

Incorporation and effect of arachidonic acid on the growth of the human K562 cell line.

V. Praloran, Y. Denizot, V. Desplat, 1999, Cancer letters.

Autophagy Targeting and Hematological Mobilization in FLT3-ITD Acute Myeloid Leukemia Decrease Repopulating Capacity and Relapse by Inducing Apoptosis of Committed Leukemic Cells

A. Bidet, A. Pigneux, Z. Ivanovic, 2022, Cancers.

Synthesis of new pyrrolo[1,2-a]quinoxaline derivatives as potential inhibitors of Akt kinase.

C. Jarry, D. Thiolat, S. Massip, 2008, Journal of enzyme inhibition and medicinal chemistry.

Synthesis, Crystal Structure and Anti-Leukemic Activity

M. Marchivie, N. Pinaud, V. Desplat, 2020 .

1-Methyl-3-{4-[(4-(2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidin-1-yl)benzyl]}-2-phenylindole

V. Desplat, J. Guillon, Solène Savrimoutou, 2018, Molbank.

Chronic myeloid leukemia progenitor cells require autophagy when leaving hypoxia-induced quiescence

M. Priault, F. Mahon, J. Chevaleyre, 2017, Oncotarget.

Chronic myeloid leukemia progenitor cells require autophagy when leaving hypoxia-induced quiescence

M. Priault, F. Mahon, J. Chevaleyre, 2017, Oncotarget.

Arachidonic acid and freshly isolated human bone marrow mononuclear cells.

V. Praloran, Y. Denizot, V. Desplat, 1999, Mediators of Inflammation.

Arachidonic acid and human bone marrow stromal cells.

V. Praloran, Y. Denizot, V. Desplat, 1998, Biochimica et biophysica acta.

Effects of lipoxygenase metabolites of arachidonic acid on the growth of human mononuclear marrow cells and marrow stromal cell cultures.

V. Praloran, Y. Denizot, V. Desplat, 1998, Mediators of inflammation.

Effects of lipidic mediators on the growth of human myeloid and erythroid marrow progenitors.

V. Praloran, Y. Denizot, V. Desplat, 1997, Journal of lipid mediators and cell signalling.

Effects of lipoxygenase metabolites of arachidonic acid on the growth of human blood CD34(+) progenitors.

V. Praloran, Z. Ivanovic, Y. Denizot, 2000, Blood cells, molecules & diseases.

Is the COX-2 effect on accelerated hematopoiesis mediated by prostaglandin E2?

V. Praloran, Y. Denizot, V. Desplat, 2000, Experimental hematology.

Expression of Platelet‐Activating Factor Receptor Transcript‐1 but Not Transcript‐2 by Human Bone Marrow Cells

V. Praloran, Y. Denizot, V. Desplat, 1999, Stem cells.

Basis of a FTIR spectroscopy methodology for automated evaluation of Akt kinase inhibitor on leukemic cell lines used as model

G. Déléris, Adrian Travo, V. Desplat, 2012, Analytical and Bioanalytical Chemistry.

Synthesis, Crystal Structure and Anti-Leukemic Activity of (E)-Pyrrolo[1,2-a]quinoxalin-4-yl)-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one

V. Baylot, N. Pinaud, V. Desplat, 2023, Molbank.

Synthesis, Crystal Structure and Anti-Leukemic Activity of 1,3-Dihydro-1-{1-[4-(4-phenylpyrrolo[1,2-a]quinoxalin-3-yl)benzyl]piperidin-4-yl}-2H-benzimidazol-2-one

N. Pinaud, V. Desplat, J. Guillon, 2022, Molbank.

1-Phenyl-8-[[4-(pyrrolo[1,2-a]quinoxalin-4-yl)phenyl]methyl]-1,3,8-triazaspiro[4.5]decan-4-one: Synthesis, Crystal Structure and Anti-Leukemic Activity

M. Marchivie, N. Pinaud, V. Desplat, 2020, Molbank.

Effects of lipoxygenase metabolites of arachidonic acid on the growth of human mononuclear marrow cells and marrow stromal cell cultures.

V. Praloran, Y. Denizot, V. Desplat, 1998 .

New 2,4-bis[(substituted-aminomethyl)phenyl]phenylquinazoline and 2,4-bis[(substituted-aminomethyl)phenyl]phenylquinoline Derivatives: Synthesis and Biological Evaluation as Novel Anticancer Agents by Targeting G-Quadruplex

J. Mergny, Y. Idrissi, I. Zupkó, 2023, Pharmaceuticals.

New ferrocenic pyrrolo[1,2-a]quinoxaline derivatives: synthesis, and in vitro antimalarial activity.

V. Sinou, D. Parzy, C. Jarry, 2008, Bioorganic & medicinal chemistry.